NF-κB/MAPK-IN-2

CAT: 0804-HY-168482Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-168482Size:1 Each
Selected
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
NF-κB/MAPK-IN-2 (compound 14) is a potent NF-κB and MAPK Inhibitor. NF-κB/MAPK-IN-2 decreases the protein expression of p-p65, p-IκB, p-p38, p-JNK, and p-ERK. NF-κB/MAPK-IN-2 reduces the LPS-induced release of TNF-α and IL-6. NF-κB/MAPK-IN-2 inhibits nuclear translocation of p65 and c-Fos. NF-κB/MAPK-IN-2 has the potential for the research of sepsis[1].
UNSPSC
12352005
Target
NF-κB; p38 MAPK
Related Pathways
MAPK/ERK Pathway; NF-κB
Field of Research
Cancer
Smiles
C[C@]1(C2=C(C[C@]3([C@@]1([H])CC[C@@]4([C@]3([H])CC=C5[C@]4(CC[C@@]6([C@@]5([H])CC(C)(CC6)C)C(OCC7=CC=CC=C7)=O)C)C)C)C(C(OCC)=O)=NO2)COC(CCC(N8CCOCC8)=O)=O
Molecular Formula
C49H66N2O9
Molecular Weight
827.06
References & Citations
[1]Xie W, et al. Design and Synthesis of Hederagenin Derivatives for the Treatment of Sepsis by Targeting TAK1 and Regulating the TAK1-NF-κB/MAPK Signaling. J Med Chem. 2025 Jan 16.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Popular Products